3D vascularized microtumors unveil aberrant ccRCC vasculature and differential sensitivity to targeted treatments
Preprint
Abstract
Clear cell renal cell carcinoma (ccRCC) is largely driven by Von Hippel Lindau (VHL) protein deficiency, promoting epithelial-mesenchymal transition, invasion, and hypervascularization, mediated by vascular endothelial growth factor (VEGF) signaling resulting in a structurally abnormal capillary network, which remains insufficiently defined. Previous studies correlating patient outcome with microvascular density yielded diverse results, underscoring the limitations of conventional parameters to fully capture vascular complexity. While VEGF-targeted anti-angiogenic first-line therapies such as sunitinib prolong progression-free survival in metastatic ccRCC, their efficacy is hampered by resistance mechanisms. This study aims to elucidate the three-dimensional architecture of ccRCC-specific vasculature in the tumor microenvironment, and its response to targeted therapies. Analysis of human ccRCC samples identified two distinct vascular structures, markedly differing from tumor capillaries, termed ponds and sheets, which were further characterized in patient-derived xenografts using advanced 3D microscopy on optically cleared samples. Ponds are large, dilated, irregular structures with wide cavity, whereas sheets are thin, elongated, and collapsed structures. To further dissect endothelial network morphogenesis, we developed an innovative in vitro 3D vascularized microtumor model, faithfully recapitulating the aberrant pond architecture. Dynamic live imaging unraveled the temporal relationship between tumor invasion and pond morphogenesis. Additionally, drug sensitivity assays demonstrated that ponds exhibit lower responsiveness to sunitinib compared to tumor capillaries. Altogether, our 3D model not only captures a specific architecture of ccRCC vascular network but also provides mechanistic insight into its development and therapeutic sensitivity. This model offers a promising avenue for personalized treatment assessment and for identification of novel therapeutic strategies. Statement of significance: A co-culture-engineered model integrating tumor spheroid invasion and capillary morphogenesis recapitulates the ccRCC endothelial structures and their response to treatments.Keywords
This publication has 52 references indexed in Scilit:
- First and Second-line Treatments in Metastatic Renal Cell CarcinomaEuropean Urology, 2024
- Volumetric imaging of the tumor microvasculature reflects outcomes and genomic states of clear cell renal cell carcinomaThe Journal of Pathology: Clinical Research, 2024
- 3D spheroid culture to examine adaptive therapy response in invading tumor cellsIn vitro models, 2022
- Patient‐derived renal cell carcinoma organoids for personalized cancer therapyClinical and Translational Medicine, 2022
- Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancerImmunity, 2022
- Microvascular maturation by mesenchymal stem cells in vitro improves blood perfusion in implanted tissue constructsBiomaterials, 2021
- The Extracellular Matrix Modulates the Metastatic JourneyDevelopmental Cell, 2019
- Distribution of Vascular Patterns in Different Subtypes of Renal Cell Carcinoma. A Morphometric Study in Two Distinct Types of Blood VesselsPathology and Oncology Research, 2017
- Major Action of Endogenous Lysyl Oxidase in Clear Cell Renal Cell Carcinoma Progression and Collagen Stiffness Revealed by Primary Cell CulturesThe American Journal of Pathology, 2016
- Fibrillogenesis in Dense Collagen Solutions: A Physicochemical StudyJournal of Molecular Biology, 2008